Cargando…
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
The introduction of immune checkpoint inhibitors (ICIs) for the treatment of solid cancers dramatically turned the tables in clinical routine. However, therapy success is still limited with up to 70% of non-responders in patients with ICI treatment. Traditionally, most immunotherapy approaches aim a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024158/ https://www.ncbi.nlm.nih.gov/pubmed/36731326 http://dx.doi.org/10.1016/j.esmoop.2022.100776 |